Ursula Wandl

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

Ursula Wandl, M. Nagel‐Hiemke, Dieter May et al. · Clinical Immunology and Immunopathology · 1992 · 163 citations

Rheumatology, Autoimmune Disease, Lupus +10

Combination therapy with interferon alpha‐2b plus low‐dose interferon gamma in pretreated patients with Ph‐positive chronic myelogenous leukaemia

Ursula Wandl, O. Kloke, M. Nagel‐Hiemke et al. · British Journal of Haematology · 1992 · 33 citations

Long-Term Treatment of Chronic Myelogenous Leukemia with Different Interferons: Results from Three Studies

N. Niederle, O. Kloke, Ursula Wandl et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 32 citations

Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients

N. Niederle, Thomas Moritz, O. Kloke et al. · European Journal of Cancer and Clinical Oncology · 1991 · 16 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Tumor necrosis factor α modifies resistance to interferon α in vivo: First clinical data

Thomas Moritz, O. Kloke, M. Nagel‐Hiemke et al. · Cancer Immunology Immunotherapy · 1992 · 10 citations · Full text

Inflammation, Cytokine, Innate Immune System +9